These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1481866)

  • 1. Suppressed serum and urine levels of indoxyl sulfate by oral sorbent in experimental uremic rats.
    Niwa T; Miyazaki T; Hashimoto N; Hayashi H; Ise M; Uehara Y; Maeda K
    Am J Nephrol; 1992; 12(4):201-6. PubMed ID: 1481866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of oral sorbent, AST-120, on serum concentration of indoxyl sulfate in uremic rats].
    Niwa T; Yazawa T; Maeda K; Ise M; Sugano M; Kodama T; Uehara Y
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):695-701. PubMed ID: 2120492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients.
    Niwa T; Tsukushi S; Ise M; Miyazaki T; Tsubakihara Y; Owada A; Shiigai T
    Miner Electrolyte Metab; 1997; 23(3-6):179-84. PubMed ID: 9387112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry.
    Kikuchi K; Itoh Y; Tateoka R; Ezawa A; Murakami K; Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(29):2997-3002. PubMed ID: 20870466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients.
    Niwa T; Nomura T; Sugiyama S; Miyazaki T; Tsukushi S; Tsutsui S
    Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats.
    Niwa T; Yazawa T; Ise M; Sugano M; Kodama T; Uehara Y; Maeda K
    Nephron; 1991; 57(1):84-8. PubMed ID: 1904558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of indoxyl-beta-D-glucuronide in uremic serum: suppression of its production by oral sorbent and efficient removal by hemodialysis.
    Niwa T; Miyazaki T; Tsukushi S; Maeda K; Tsubakihara Y; Owada A; Shiigai T
    Nephron; 1996; 74(1):72-8. PubMed ID: 8883023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.
    Niwa T; Ise M
    J Lab Clin Med; 1994 Jul; 124(1):96-104. PubMed ID: 8035108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia.
    Lim CF; Bernard BF; de Jong M; Docter R; Krenning EP; Hennemann G
    J Clin Endocrinol Metab; 1993 Feb; 76(2):318-24. PubMed ID: 8432774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uremic toxicity of indoxyl sulfate.
    Niwa T
    Nagoya J Med Sci; 2010 Feb; 72(1-2):1-11. PubMed ID: 20229698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive effects of an oral sorbent on nephropathy in rats.
    Aoyama I; Miyazaki T; Niwa T
    Miner Electrolyte Metab; 1999; 25(4-6):365-72. PubMed ID: 10681668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC; Tomino Y; Lu KC
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral sorbent AST-120 increases renal NO synthesis in uremic rats.
    Tumur Z; Niwa T
    J Ren Nutr; 2008 Jan; 18(1):60-4. PubMed ID: 18089446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
    Niwa T
    Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with benazepril and oral adsorbent ameliorates progressive renal fibrosis in uremic rats.
    Aoyama I; Shimokata K; Niwa T
    Nephron; 2002 Mar; 90(3):297-312. PubMed ID: 11867951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uremic rats.
    Niwa T; Ise M; Miyazaki T; Meada K
    Nephron; 1993; 65(1):82-7. PubMed ID: 8413797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys.
    Miyazaki T; Aoyama I; Ise M; Seo H; Niwa T
    Nephrol Dial Transplant; 2000 Nov; 15(11):1773-81. PubMed ID: 11071964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate.
    Niwa T; Ise M; Miyazaki T
    Am J Nephrol; 1994; 14(3):207-12. PubMed ID: 7977482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoxyl sulfate is a nephro-vascular toxin.
    Niwa T
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S2-6. PubMed ID: 20797565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting protein-bound uremic toxins in chronic kidney disease.
    Niwa T
    Expert Opin Ther Targets; 2013 Nov; 17(11):1287-301. PubMed ID: 23941498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.